Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Pneumococcal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global pneumococcal vaccine market size reached US$ 8.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.6 Billion by 2027, exhibiting a growth rate (CAGR) of 5.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Pneumococcal disease is caused by Streptococcus pneumoniae bacterium that can lead to severe infection of the lungs (pneumonia) and blood (bacteremia) or the lining of the brain and spinal cord (meningitis). The vaccines help protect both children and adults by stimulating the immune system and protecting against the bacterial strains responsible for severe infections. As these vaccines help prevent infection from spreading, reduce fatality rate and eliminate the need for hospitalization, they are widely being used across the globe.

According to the World Health Organization (WHO), children under 2-5 years of age are at a high risk of developing pneumococcal disease. This, in confluence with the escalating number of birth rates and the growing concerns among parents about the health of their children, represents one of the major factors bolstering the market growth. Additionally, the increasing geriatric population is contributing to the market growth. This can also be accredited to the contagiousness of the disease, which can cause severe complications in older adults. Furthermore, the rising number of smokers and individuals living with chronic health conditions is positively influencing the market growth. Moreover, the introduction of the Pneumococcal Conjugate Vaccine (PCV) in infant routine immunization by governing agencies of numerous countries is anticipated to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pneumococcal vaccine market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on vaccine type, product type, distribution channel and end user.

Breakup by Vaccine Type:

  • Pneumococcal Conjugate Vaccine
  • Pneumococcal Polysaccharide Vaccine
     

Breakup by Product Type:

  • Prevnar 13
  • Synflorix
  • Pneumovax 23
     

Breakup by Distribution Channel:

  • Distribution Partner Companies
  • Non-Governmental Organizations (NGO)
  • Government Authorities
     

Breakup by End User:

  • Pediatrics
  • Adults
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt Ltd and Walvax Biotechnology Co. Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Vaccine Type, Product Type, Distribution Channel, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Astellas Pharma Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt Ltd and Walvax Biotechnology Co. Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global pneumococcal vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pneumococcal vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pneumococcal vaccine market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Pneumococcal Vaccine Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Vaccine Type
     6.1   Pneumococcal Conjugate Vaccine
        6.1.1  Market Trends
        6.1.2  Market Forecast
     6.2   Pneumococcal Polysaccharide Vaccine
        6.2.1  Market Trends
        6.2.2  Market Forecast
7    Market Breakup by Product Type
     7.1   Prevnar 13
        7.1.1  Market Trends
        7.1.2  Market Forecast
     7.2   Synflorix
        7.2.1  Market Trends
        7.2.2  Market Forecast
     7.3   Pneumovax 23
        7.3.1  Market Trends
        7.3.2  Market Forecast
8    Market Breakup by Distribution Channel
     8.1   Distribution Partner Companies
        8.1.1  Market Trends
        8.1.2  Market Forecast
     8.2   Non-Governmental Organizations (NGO)
        8.2.1  Market Trends
        8.2.2  Market Forecast
     8.3   Government Authorities
        8.3.1  Market Trends
        8.3.2  Market Forecast
9    Market Breakup by End User
     9.1   Pediatrics
        9.1.1  Market Trends
        9.1.2  Market Forecast
     9.2   Adults
        9.2.1  Market Trends
        9.2.2  Market Forecast
10   Market Breakup by Region
     10.1   North America
          10.1.1   United States
               10.1.1.1  Market Trends
               10.1.1.2  Market Forecast
          10.1.2   Canada
               10.1.2.1  Market Trends
               10.1.2.2  Market Forecast
     10.2   Asia-Pacific
          10.2.1   China
               10.2.1.1  Market Trends
               10.2.1.2  Market Forecast
          10.2.2   Japan
               10.2.2.1  Market Trends
               10.2.2.2  Market Forecast
          10.2.3   India
               10.2.3.1  Market Trends
               10.2.3.2  Market Forecast
          10.2.4   South Korea
               10.2.4.1  Market Trends
               10.2.4.2  Market Forecast
          10.2.5   Australia
               10.2.5.1  Market Trends
               10.2.5.2  Market Forecast
          10.2.6   Indonesia
               10.2.6.1  Market Trends
               10.2.6.2  Market Forecast
          10.2.7   Others
               10.2.7.1  Market Trends
               10.2.7.2  Market Forecast
     10.3   Europe
          10.3.1   Germany
               10.3.1.1  Market Trends
               10.3.1.2  Market Forecast
          10.3.2   France
               10.3.2.1  Market Trends
               10.3.2.2  Market Forecast
          10.3.3   United Kingdom
               10.3.3.1  Market Trends
               10.3.3.2  Market Forecast
          10.3.4   Italy
               10.3.4.1  Market Trends
               10.3.4.2  Market Forecast
          10.3.5   Spain
               10.3.5.1  Market Trends
               10.3.5.2  Market Forecast
          10.3.6   Russia
               10.3.6.1  Market Trends
               10.3.6.2  Market Forecast
          10.3.7   Others
               10.3.7.1  Market Trends
               10.3.7.2  Market Forecast
     10.4   Latin America
          10.4.1   Brazil
               10.4.1.1  Market Trends
               10.4.1.2  Market Forecast
          10.4.2   Mexico
               10.4.2.1  Market Trends
               10.4.2.2  Market Forecast
          10.4.3   Others
               10.4.3.1  Market Trends
               10.4.3.2  Market Forecast
     10.5   Middle East and Africa
          10.5.1  Market Trends
          10.5.2  Market Breakup by Country
          10.5.3  Market Forecast
11  SWOT Analysis
    11.1   Overview
    11.2   Strengths
    11.3   Weaknesses
    11.4   Opportunities
    11.5   Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1   Overview
    13.2   Bargaining Power of Buyers
    13.3   Bargaining Power of Suppliers
    13.4   Degree of Competition
    13.5   Threat of New Entrants
    13.6   Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1   Market Structure
    15.2   Key Players
    15.3   Profiles of Key Players
         15.3.1   Astellas Pharma Inc.
              15.3.1.1   Company Overview
              15.3.1.2   Product Portfolio
              15.3.1.3   Financials
              15.3.1.4   SWOT Analysis
         15.3.2   GlaxoSmithKline Plc.
              15.3.2.1   Company Overview
              15.3.2.2   Product Portfolio
              15.3.2.3   Financials
              15.3.2.4   SWOT Analysis
         15.3.3   Merck & Co. Inc.
              15.3.3.1   Company Overview
              15.3.3.2   Product Portfolio
              15.3.3.3   Financials
              15.3.3.4   SWOT Analysis
         15.3.4   Panacea Biotec Ltd.
              15.3.4.1   Company Overview
              15.3.4.2   Product Portfolio
              15.3.4.3   Financials
              15.3.4.4   SWOT Analysis
         15.3.5   Pfizer Inc.
              15.3.5.1   Company Overview
              15.3.5.2   Product Portfolio
              15.3.5.3   Financials
              15.3.5.4   SWOT Analysis
         15.3.6   Sanofi S.A.
              15.3.6.1   Company Overview
              15.3.6.2   Product Portfolio
              15.3.6.3   Financials
              15.3.6.4   SWOT Analysis
         15.3.7   Serum Institute of India Pvt Ltd.
              15.3.7.1   Company Overview
              15.3.7.2   Product Portfolio
         15.3.8   Walvax Biotechnology Co. Ltd.
              15.3.8.1   Company Overview
              15.3.8.2   Product Portfolio
              15.3.8.3   Financials

List of Figures

Figure 1: Global: Pneumococcal Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Pneumococcal Vaccine Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Pneumococcal Vaccine Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Pneumococcal Vaccine Market: Breakup by Vaccine Type (in %), 2021
Figure 5: Global: Pneumococcal Vaccine Market: Breakup by Product Type (in %), 2021
Figure 6: Global: Pneumococcal Vaccine Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Pneumococcal Vaccine Market: Breakup by End User (in %), 2021
Figure 8: Global: Pneumococcal Vaccine Market: Breakup by Region (in %), 2021
Figure 9: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Pneumococcal Vaccine (Prevnar 13) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Pneumococcal Vaccine (Prevnar 13) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Pneumococcal Vaccine (Synflorix) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Pneumococcal Vaccine (Synflorix) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Pneumococcal Vaccine (Pneumovax 23) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Pneumococcal Vaccine (Pneumovax 23) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Pneumococcal Vaccine (Government Authorities) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Pneumococcal Vaccine (Government Authorities) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Pneumococcal Vaccine (Pediatrics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Pneumococcal Vaccine (Pediatrics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Pneumococcal Vaccine (Adults) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Pneumococcal Vaccine (Adults) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: North America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: North America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: United States: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Canada: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Canada: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia-Pacific: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia-Pacific: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: China: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: China: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Japan: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Japan: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: India: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: India: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: South Korea: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: South Korea: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Australia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Australia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Indonesia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Indonesia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Europe: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Europe: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Germany: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Germany: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: France: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: France: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United Kingdom: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United Kingdom: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Italy: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Italy: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Spain: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Spain: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Russia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Russia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Latin America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Latin America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Brazil: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Brazil: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Mexico: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Mexico: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Middle East and Africa: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Middle East and Africa: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Pneumococcal Vaccine Market: Breakup by Country (in %), 2021
Figure 78: Global: Pneumococcal Vaccine Industry: SWOT Analysis
Figure 79: Global: Pneumococcal Vaccine Industry: Value Chain Analysis
Figure 80: Global: Pneumococcal Vaccine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pneumococcal Vaccine Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pneumococcal Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2022-2027
Table 3: Global: Pneumococcal Vaccine Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 4: Global: Pneumococcal Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Pneumococcal Vaccine Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Pneumococcal Vaccine Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Pneumococcal Vaccine Market: Competitive Structure
Table 8: Global: Pneumococcal Vaccine Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links